Amyloid-Journal of Protein Folding Disorders

Papers
(The TQCC of Amyloid-Journal of Protein Folding Disorders is 5. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-02-01 to 2025-02-01.)
ArticleCitations
Changes in the amyloid editorial board members and in editor positions177
Neurological manifestations of hereditary transthyretin amyloidosis: a focus on diagnostic delays146
A second case of liraglutide-type localised amyloidosis71
Prevalence and diagnostic value of extra-left ventricle echocardiographic findings in transthyretin-related cardiac amyloidosis64
Phenotype and clinical outcomes of Glu89Lys hereditary transthyretin amyloidosis: a new endemic variant in Spain43
The way to a man’s heart: prostate samples for the early detection of transthyretin cardiomyopathy29
Iatrogenic cerebral amyloid angiopathy rather than sporadic CAA in younger adults with lobar intracerebral haemorrhage27
A novel substitution of proline (P32L) destabilises β2-microglobulin inducing hereditary systemic amyloidosis25
Technetium-99m-pyrophosphate imaging-based computed tomography-guided core-needle biopsy of internal oblique muscle in wild-type transthyretin cardiac amyloidosis19
Post-translational modification of amyloid a protein in patients with AA amyloidosis18
Diagnostic and prognostic contribution of DPD scintigraphy in transthyretin V30M cardiac amyloidosis15
Steep increase in the number of transthyretin-positive cardiac biopsy cases in Japan: evidence obtained by the nation-wide pathology consultation for the typing diagnosis of amyloidosis14
Early events in light chain aggregation at physiological pH reveal new insights on assembly, stability, and aggregate dissociation14
Mapping cellular response to destabilized transthyretin reveals cell- and amyloidogenic protein-specific signatures14
Oxidative conversion of transthyretin in formalin-fixed clinical amyloid samples results in the formation of the His90Asp and His90Asn variants13
Pupillometric findings in ATTRv patients and carriers: results from a single-centre experience13
A multicentric study of the disease risks and first manifestations in hereditary transthyretin amyloidosis (ATTRv): insights for an earlier diagnosis12
Incidence of light chain amyloidosis in Florence metropolitan area, Italy: a population-based study12
Utilization and tolerance of beta-blockers among patients with AL amyloidosis11
High frequency of occult transthyretin and apolipoprotein AI–type amyloid in aortic valves removed by valve replacement for aortic stenosis10
Whole tissue proteomic analyses of cardiac ATTR and AL unveil mechanisms of tissue damage9
Tissue biopsy for the diagnosis of amyloidosis: experience from some centres9
Effects of eplontersen on symptoms of autonomic neuropathy in hereditary transthyretin-mediated amyloidosis: secondary analysis from the NEURO-TTRansform trial9
Metabolomics analysis for diagnosis and biomarker discovery of transthyretin amyloidosis9
Amyloid nomenclature 2024: update, novel proteins, and recommendations by the International Society of Amyloidosis (ISA) Nomenclature Committee9
Refining prognostication in systemic AL amyloidosis: limited value of dFLC9
In memoriam: Lawreen Connors, Ph.D.8
Clinical and molecular insights into A97S variants in hereditary transthyretin amyloid polyneuropathy in South China8
A case of asymmetric insulin-derived localised amyloid deposition associated with long-acting insulin analog administration8
An updated AL-base reveals ranked enrichment of immunoglobulin light chain variable genes in AL amyloidosis8
Real-world treatment patterns, costs, and outcomes in patients with AL amyloidosis: analysis of the Optum EHR and commercial claims databases7
Neurological involvement in Ile68Leu (p.Ile88Leu) ATTR amyloidosis: not only a cardiogenic mutation7
Comparison between tafamidis and liver transplantation as first-line therapy for hereditary transthyretin amyloidosis7
Brain MRI in patients with V30M hereditary transthyretin amyloidosis7
Monitoring of cardiac transthyretin amyloid load by [99mTc]DPD scintigraphy: is it the end of the semi-quantitative evaluation?7
Characterization of population genetic structure of hereditary transthyretin amyloidosis in Bulgaria6
Possible transmission of leukocyte chemotactic factor 2 amyloidosis after interpopulational liver transplantation6
A novel APOA1 frameshift mutation Glu120Glyfs*60 with upper gastrointestinal involvement and an indolent course6
A rare occurrence and near miss! Should a TTR gene test be routinely performed for suspected ATTR-cardiomyopathy?6
The integration of genetically-regulated transcriptomics and electronic health records highlights a pattern of medical outcomes related to increased hepatic transthyretin expression6
Impact of baseline polyneuropathy severity on patisiran treatment outcomes in the APOLLO trial6
Gastrointestinal Amyloid Screening Study (GASS): is screening for amyloid in the gastrointestinal tract useful?6
Symptomatic SARS-CoV2 infection associated with high mortality in AA amyloidosis5
Prevalence of amyloid in ligamentum flavum of patients with lumbar spinal stenosis5
Amyloidosis from the patient perspective: the French daily impact of amyloidosis study5
Neurofilament light chain as a biomarker for hereditary ATTR amyloidosis − correlation between neurofilament light chain and nerve conduction study5
Delayed identification of monoclonal protein is associated with early death in isolated cardiac AL amyloidosis5
PRX004 in variant amyloid transthyretin (ATTRv) amyloidosis: results of a phase 1, open-label, dose-escalation study5
Neurofilament light chain kinetics as a biomarker for polyneuropathy in V122I hereditary transthyretin amyloidosis5
T2-relaxometry in a large cohort of hereditary transthyretin amyloidosis with polyneuropathy5
Impact of cytogenetic abnormalities on treatment outcomes in patients with amyloid light-chain amyloidosis: subanalyses from the ANDROMEDA study5
Clinicopathological features of clinically undiagnosed sporadic transthyretin cardiac amyloidosis: a forensic autopsy-based series5
Amyloid nomenclature 2022: update, novel proteins, and recommendations by the International Society of Amyloidosis (ISA) Nomenclature Committee5
0.044174909591675